Resting heart rate: a modifiable prognostic indicator of cardiovascular risk and outcomes? - Wikidata - thesis-toulmin - TriplyDB

Resting heart rate: a modifiable prognostic indicator of cardiovascular risk and outcomes?

Resting heart rate: a modifiable prognostic indicator of cardiovascular risk and outcomes?

http://www.wikidata.org/entity/Q34774214

about

Erectile dysfunction, physical activity and metabolic syndrome: differences in markers of atherosclerosis.Relationship of resting heart rate and physical activity with insulin sensitivity in a population-based survey Is abnormal glucose tolerance in antipsychotic-naive patients with nonaffective psychosis confounded by poor health habits?Exercise in a healthy heart program: a cohort study Resting sinus heart rate and first degree av block: modifiable risk predictors or epiphenomena?Protective role of resting heart rate on all-cause and cardiovascular disease mortality.Assessment of potential cardiovascular risks of methylphenidate in comparison with sibutramine: do we need a SCOUT (trial)?Ivabradine: Do the Benefits Outweigh the Risks?Utilization of second derivative photoplethysmographic features for myocardial infarction classification.

P2860

Q31021424-82DB924F-C1FD-4964-84F5-D03B50498B11 Q35599690-3356C164-DF16-4755-81DF-55BC24605695 Q35768175-467AEC62-4BA0-431D-8097-CF12D6E1DB82 Q37195877-D0E27129-8EA1-4759-8C6F-2BD8F74FF4CF Q37398110-596162B9-B786-48C1-8F8D-E8F1E5C2406A Q37537663-2779C37A-6CF8-47E2-AFC4-DC8746A33D47 Q38242438-E12DEBC5-0E97-4511-AC60-B0634D47736F Q38971288-53935D0B-A4AC-4730-917E-4FE16B566EE1 Q50767599-6B93B119-692B-4AB9-AB98-8C279441ED7D

P2860

Resting heart rate: a modifiable prognostic indicator of cardiovascular risk and outcomes?

http://www.wikidata.org/entity/Q34774214

description

2008 nî lūn-bûn

@nan

2008 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Resting heart rate: a modifiab ...... diovascular risk and outcomes?

@ast

Resting heart rate: a modifiab ...... diovascular risk and outcomes?

@en

Resting heart rate: a modifiab ...... diovascular risk and outcomes?

@nl

type

label

Resting heart rate: a modifiab ...... diovascular risk and outcomes?

@ast

Resting heart rate: a modifiab ...... diovascular risk and outcomes?

@en

Resting heart rate: a modifiab ...... diovascular risk and outcomes?

@nl

prefLabel

Resting heart rate: a modifiab ...... diovascular risk and outcomes?

@ast

Resting heart rate: a modifiab ...... diovascular risk and outcomes?

@en

Resting heart rate: a modifiab ...... diovascular risk and outcomes?

@nl

P1433

Q34774214-71F79D28-3727-4CF3-81B8-D5F921A44838

P1476

Q34774214-DDBCB3F6-7BC8-4096-81B3-EFBC7DC0EA92

P2093

Q34774214-1B1EA03D-C752-4D75-8624-8D20A81BC830

Q34774214-2A09344B-99A7-4873-A8E2-7FFAFBE71594

Q34774214-594EFF94-0D86-4270-8ACC-0826E32388EF

Q34774214-BCBEB04B-DA87-4D48-B7B2-384DFA485910

Q34774214-ECE7FB4B-3944-4A91-A02D-34EA0891999A

P2860

Q34774214-03C97A6B-34D1-4D6B-A079-5704077D7EAF

Q34774214-0C04586F-79C0-4485-B729-E8FF744E36E9

Q34774214-24F05969-E605-4506-A093-1CEF34605A0E

Q34774214-301E2C7E-F569-491A-A22A-669026155E06

Q34774214-43E1DCCD-18A2-483A-92C9-C02941A3769B

Q34774214-45CF7D4C-ABBB-401C-9A05-445EC23E1465

Q34774214-4BBB3426-1767-4234-ADF4-0DE1D40F1B04

Q34774214-4C6914D8-C0CB-4989-A3C6-F603B3B620C3

Q34774214-5E140010-2DAC-451C-984F-49999F07A47C

Q34774214-75DAE00B-5F80-47A6-BDFE-CAB0820C9C85

P304

Q34774214-52A868AE-B5FC-45D4-A8A7-4C5104D3DB27

P31

Q34774214-6171CB8A-F0FA-4AD3-B974-FB6DB47FCDBB

P356

Q34774214-14F3E40B-8A21-4166-97BD-FAE8C0C8FB75

P478

Q34774214-6604E2F8-C804-45C3-9325-B68254249291

P577

Q34774214-954E626E-8F98-41F3-BBF4-118E85484282

P698

Q34774214-DF75AD25-F779-4C7B-A0EC-A60E132C8CFC

P932

Q34774214-33AFEBDF-EE61-45C3-A867-CB4156A679DB

P356

S0828-282X(08)71019-5

P1433

The Canadian Journal of Cardiology

P1476

Resting heart rate: a modifiab ...... diovascular risk and outcomes?

@en

P2093

David H Fitchett

http://www.w3.org/2001/XMLSchema#string

Eva M Lonn

http://www.w3.org/2001/XMLSchema#string

J Malcolm Arnold

http://www.w3.org/2001/XMLSchema#string

Jean-Claude Tardif

http://www.w3.org/2001/XMLSchema#string

Jonathan G Howlett

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina

Heart rate, ischaemic heart disease, and sudden cardiac death in middle-aged British men.

Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).

Heart rate lowering by specific and selective I(f) current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease.

Elevated heart rate: a major risk factor for cardiovascular disease.

Tachycardia-induced cardiomyopathy: a review of literature.

Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management.

Impact of increased heart rate on clinical outcomes in hypertension: implications for antihypertensive drug therapy.

Heart failure in patients with left ventricular systolic dysfunction.

Can we improve cardiovascular risk prediction beyond risk equations in the physician's office?

P304

3A-8A

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0828-282X(08)71019-5

http://www.w3.org/2001/XMLSchema#string

P478

24 Suppl A

http://www.w3.org/2001/XMLSchema#string

P577

2008-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18437251

http://www.w3.org/2001/XMLSchema#string

P932

2787005

http://www.w3.org/2001/XMLSchema#string